2023
Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022
Shah M, Patel K, Milucky J, Taylor C, Reingold A, Armistead I, Meek J, Anderson E, Weigel A, Reeg L, Como‐Sabetti K, Ropp S, Muse A, Bushey S, Shiltz E, Sutton M, Talbot H, Chatelain R, Havers F, Team T. Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022. Influenza And Other Respiratory Viruses 2023, 17: e13107. PMID: 36875205, PMCID: PMC9981874, DOI: 10.1111/irv.13107.Peer-Reviewed Original ResearchConceptsDay of admissionSARS-CoV-2 infectionHospitalized adultsViral infectionBacterial coinfectionCOVID-19Laboratory-confirmed SARS-CoV-2 infectionBacterial infectionsPopulation-based surveillance systemRhinovirus/enterovirusRespiratory syncytial virusBacterial pathogensCoV-2 virusClinical featuresClinical outcomesViral coinfectionSyncytial virusHuman metapneumovirusParainfluenza virusRisk factorsSterile sitesEndemic coronavirusesRelative riskRelevant bacterial pathogensGram-negative rods
2022
2314. Hospitalizations and Antibiotic Use in the Year Prior to an Incident C. difficile Infection for Medicare Beneficiaries in Four States, 2016–2018
Hatfield K, Baggs J, Reddy S, Aranmolate R, Meek J, Fridkin S, Szydlowski J, Hatwar T, Dumyati G, Watkins J, Wilson C, McDonald L, Jernigan J, Guh A. 2314. Hospitalizations and Antibiotic Use in the Year Prior to an Incident C. difficile Infection for Medicare Beneficiaries in Four States, 2016–2018. Open Forum Infectious Diseases 2022, 9: ofac492.146. PMCID: PMC9752406, DOI: 10.1093/ofid/ofac492.146.Peer-Reviewed Original ResearchOutpatient antibiotic useEmerging Infections ProgramClostridioides difficile infectionAntibiotic useCDI casesDifficile infectionRisk factorsMedicare beneficiariesPrevention's Emerging Infections ProgramAntibiotic classesPrior yearAntibiotic stewardship effortsC. difficile infectionMultiple risk factorsInpatient hospitalization dataMedicare Provider AnalysisTiming of hospitalizationGrant/research supportDifferent antibiotic classesAntibiotic prescriptionsCase patientsMedian lengthOutpatient antibioticsCDI surveillanceCDI diagnosis
2021
Risk Factors for Severe COVID-19 in Children
Woodruff R, Campbell A, Taylor C, Chai S, Kawasaki B, Meek J, Anderson E, Weigel A, Monroe M, Reeg L, Bye E, Sosin D, Muse A, Bennett N, Billing L, Sutton M, Talbot H, McCaffrey K, Pham H, Patel K, Whitaker M, McMorrow M, Havers F. Risk Factors for Severe COVID-19 in Children. Pediatrics 2021, 149: e2021053418. PMID: 34935038, PMCID: PMC9213563, DOI: 10.1542/peds.2021-053418.Peer-Reviewed Original ResearchConceptsSevere COVID-19Adjusted risk ratioPopulation-based ratesHospitalized childrenRisk factorsCOVID-19Laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infectionAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionSevere coronavirus disease 2019COVID-19-Associated Hospitalization Surveillance NetworkNon-Hispanic black childrenCoronavirus 2 infectionChronic lung diseaseConfidence intervalsCoronavirus disease 2019COVID-19 vaccineTube dependenceAirway abnormalitiesDiabetes mellitusIllness severityLung diseaseRisk ratioMedical records
2018
482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015
Skrobarcek K, Mu Y, Ahern J, Beldavs Z, Brousseau G, Dumyati G, Farley M, Holzbauer S, Kainer M, Meek J, Perlmutter R, Phipps E, Winston L, Guh A. 482. Association between Socioeconomic Status Factors and Incidence of Community-Associated Clostridium difficile Infection Utilizing Factor Analysis—United States, 2014–2015. Open Forum Infectious Diseases 2018, 5: s179-s179. PMCID: PMC6253049, DOI: 10.1093/ofid/ofy210.491.Peer-Reviewed Original ResearchClostridium difficile infectionEmerging Infections ProgramSocioeconomic status factorsCDC's Emerging Infections ProgramCA-CDI casesCDI risk factorsSES variablesDays of hospitalizationHealthcare-associated infectionsLow-income areasStatus factorsLow incomeMultivariable analysisCA-CDICDI surveillanceDifficile infectionRisk factorsIncidence rateInfections ProgramPositive testPrevention strategiesCensus tractsHealth disparitiesSocial determinantsHealth resources
2017
Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015
Niccolai LM, Meek JI, Brackney M, Hadler JL, Sosa LE, Weinberger DM. Declines in Human Papillomavirus (HPV)–Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008–2015. Clinical Infectious Diseases 2017, 65: 884-889. PMID: 28520854, DOI: 10.1093/cid/cix455.Peer-Reviewed Original ResearchConceptsCervical cancer screeningCervical lesionsRisk behaviorsHPV vaccinationVaccination coverageHuman papillomavirusCancer screeningBirth cohortHigh-grade cervical lesionsHPV vaccination coverageRates of CIN2Cervical intraepithelial neoplasiaHigh-grade lesionsSexual risk behaviorsSignificant declineHPV vaccineVaccine impactIntraepithelial neoplasiaCervical cancerRisk factorsSurveillance periodSimilar epidemiologyChlamydia trachomatisCohort patternsNegative binomial regression
2016
Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes
Hunter J, Mu Y, Dumyati G, Farley M, Winston L, Johnston H, Meek J, Perlmutter R, Holzbauer S, Beldavs Z, Phipps E, Dunn J, Cohen J, Avillan J, Stone N, Gerding D, McDonald L, Lessa F. Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes. Open Forum Infectious Diseases 2016, 3: ofv196. PMID: 26798767, PMCID: PMC4719744, DOI: 10.1093/ofid/ofv196.Peer-Reviewed Original ResearchClostridium difficile infectionDifficile infectionPatient outcomesPopulation-based surveillanceAcute care settingAppropriate antibiotic useEstimates of incidenceMedian ageSubstantial morbidityPositive stoolsMedical recordsRisk factorsAdvanced ageAntibiotic useInfection preventionAntibiotic exposureHome residentsNational incidenceCare settingsPositive specimenNational estimatesIncidenceSpecimen collectionAgeStool
2014
The Burden of Influenza Hospitalizations in Infants From 2003 to 2012, United States
Chaves S, Perez A, Farley M, Miller L, Schaffner W, Lindegren M, Sharangpani R, Meek J, Yousey-Hindes K, Thomas A, Boulton R, Baumbach J, Hancock E, Bandyopadhyay A, Lynfield R, Morin C, Zansky S, Reingold A, Bennett N, Ryan P, Fowler B, Fry A, Finelli L. The Burden of Influenza Hospitalizations in Infants From 2003 to 2012, United States. The Pediatric Infectious Disease Journal 2014, 33: 912-919. PMID: 24577042, DOI: 10.1097/inf.0000000000000321.Peer-Reviewed Original ResearchConceptsImpact of influenzaHigh-risk conditionsHospitalization ratesRisk factorsOlder infantsIntensive care unit admissionInfluenza-associated hospitalization ratesCare unit admissionRisk conditionsInfluenza hospitalizationsUnit admissionICU admissionInfluenza vaccinationRespiratory failureClinical characteristicsInfant hospitalizationHealthy infantsMost hospitalizationsPregnant womenLung diseaseCardiovascular diseaseUS infantsHospitalizationYoung infantsInfantsChild, Household, and Caregiver Characteristics Associated with Hospitalization for Influenza Among Children 6–59 Months of Age
Dharan N, Sokolow L, Cheng P, Gargiullo P, Gershman K, Lynfield R, Morin C, Thomas A, Meek J, Farley M, Arnold K, Reingold A, Craig A, Schaffner W, Bennett N, Zansky S, Baumbach J, Lathrop S, Kamimoto L, Shay D. Child, Household, and Caregiver Characteristics Associated with Hospitalization for Influenza Among Children 6–59 Months of Age. The Pediatric Infectious Disease Journal 2014, 33: e141-e150. PMID: 24642518, PMCID: PMC4025593, DOI: 10.1097/inf.0000000000000283.Peer-Reviewed Original ResearchConceptsMonths of ageChildren 6Influenza hospitalizationsInfluenza illnessInfluenza vaccinationMaternal ageRisk factorsSevere outcomesChronic illnessEmerging Infections Program sitesLaboratory-confirmed influenza infectionIndependent risk factorInfluenza-associated hospitalizationsYoung maternal ageCase-control studyConditional logistic regressionYoung childrenHematologic/Influenza immunizationHousehold smokingEligible casesInfluenza infectionNeurologic conditionsEligible controlsMedical records
2011
Clostridium difficile Infection in Outpatients, Maryland and Connecticut, USA, 2002–2007 - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC
Hirshon JM, Thompson AD, Limbago B, McDonald LC, Bonkosky M, Heimer R, Meek J, Mai V, Braden C. Clostridium difficile Infection in Outpatients, Maryland and Connecticut, USA, 2002–2007 - Volume 17, Number 10—October 2011 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2011, 17: 1946-1949. PMID: 22000379, PMCID: PMC3310666, DOI: 10.3201/eid1710.110069.Peer-Reviewed Original Research